<div id="readability-page-1">Growth stocks reflect firms on track for swift expansion, beating peers and the overall market. Their strategy to reinvest profits drives continued growth, offering investors both near-term upside and long-term capital appreciation.<h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. </li><li> Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off </li></ul> One way to identify these stocks is through their past revenue or earnings growth. Today, we have shortlisted stocks whose revenue has grown at a five-year CAGR of more than 5%. Along with this parameter, we have zeroed in on stocks that have received Strong Buy ratings from Wall Street analysts. Here are this week's stocks: Insulet (PODD) – This medical device company develops the Omnipod, a tubeless insulin pump for people with diabetes. PODD stock's average price target of $381.12 implies a 28.36% upside potential from the current level. The company's revenue has grown at a five-year CAGR of 18.02%. Importantly, TipRanks AI Analyst expects PODD's revenue to grow by 27.75%, compared with the Healthcare sector's average of 22.53%. Insulet's revenue growth is fueled by strong adoption of Omnipod 5, an automated insulin delivery (AID) system, international expansion, and new Continuous Glucose Monitor integrations. Autodesk (ADSK) – This software company provides design and engineering tools used in architecture, construction, manufacturing, and media. ADSK stock's average price target of $374.79 implies an upside potential of 24.35%. Its revenue increased at a CAGR of 10.09% in the past five years. According to TipRanks AI Analyst, Autodesk's revenue is expected to grow by 15.62% in comparison to the Technology sector's average of 8.5%. Autodesk's revenue growth is aided by rising cloud adoption and AI‑enabled design tools. FUTU Holdings (FUTU) – This online brokerage and financial technology company offers digital trading and wealth management services. FUTU stock's average price target of $222.55 implies an upside potential of 29.44%. The company's revenue has grown at a five-year CAGR of 32.64%. The company's revenue is expected to rise by 81.43%, according to TipRanks AI Analyst. This compares favorably with the Financial sector's average of 9.73%. The company's revenue growth is driven by surging funded accounts, rising trading volumes, and strong international expansion, especially in Malaysia. <h2>What Is TipRanks' Smart Growth Newsletter?</h2> TipRanks' Smart Growth Newsletter provides top growth investment ideas on a weekly basis, based on TipRanks' data and analysis. The newsletter includes macroeconomic, market-wide, and company-specific analysis to help investors understand the trends that may influence their growth investments. Stay ahead of the market – subscribe now!</div>

ADSK

PODD

FUTU

Analysts recommend three growth stocks with strong buy ratings: Insulet, Autodesk, and FUTU Holdings. Insulet's revenue is driven by Omnipod 5 adoption and international expansion. Autodesk benefits from cloud adoption and AI design tools. FUTU Holdings sees growth from increased trading volumes and international expansion. TipRanks offers a Smart Growth Newsletter for investment insights.

- Growth stocks are characterized by firms poised for rapid expansion, often outperforming peers and the market.  
- The article highlights three stocks: Insulet (PODD) with a five-year revenue CAGR of 18.02%, Autodesk (ADSK) at 10.09%, and FUTU Holdings (FUTU) at 32.64%, all showing significant upside potential according to analysts.  
- These companies are experiencing growth driven by product adoption, international expansion, and technological advancements, making them attractive for investors seeking both short-term gains and long-term appreciation.

3 "Strong Buy" Growth Stocks to Buy Now, According to Analysts – 12/8/2025